Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Jacques L. Tamuzi"'
Autor:
Patrick D.M.C. Katoto, Dieudonné Bihehe, Amanda Brand, Raymond Mushi, Aline Kusinza, Brian W. Alwood, Richard N. van Zyl-Smit, Jacques L. Tamuzi, Nadia A. Sam-Agudu, Marcel Yotebieng, John Metcalfe, Grant Theron, Krystal J. Godri Pollitt, Maia Lesosky, Jeroen Vanoirbeek, Kevin Mortimer, Tim Nawrot, Benoit Nemery, Jean B. Nachega
Publikováno v:
Environmental Health, Vol 23, Iss 1, Pp 1-16 (2024)
Abstract Background In low- and middle-income countries countries, millions of deaths occur annually from household air pollution (HAP), pulmonary tuberculosis (PTB), and HIV-infection. However, it is unknown whether HAP influences PTB risk among peo
Externí odkaz:
https://doaj.org/article/248f10cb3b4142a6be9ddc0a22584326
Autor:
Patrick DMC Katoto, Mireille AM Kakubu, Jacques L. Tamuzi, Amanda S. Brand, Adaeze Ayuk, Liliane N. Byamungu, Charles S. Wiysonge, Glenda Gray
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 378-392 (2023)
Background This study aimed to evaluate the safety and effectiveness of the BNT162b2 vaccine in immunocompromised adolescents and young adults. Research design and methods The study conducted a meta-analysis of post-marketing studies examining BNT162
Externí odkaz:
https://doaj.org/article/6c5fa3c103c54850b86de5def8fc7345
Autor:
Patrick D. M. C. Katoto, Liliane N. Byamungu, Amanda S. Brand, Jacques L. Tamuzi, Mireille A. M. Kakubu, Charles S. Wiysonge, Glenda Gray
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-9 (2023)
Abstract Myocarditis and pericarditis are frequent complications of COVID-19, but have also been reported following vaccination against COVID-19 in adolescents. To build vaccine confidence and inform policy, we characterized the incidence of myocardi
Externí odkaz:
https://doaj.org/article/39b6f18d170649a5982e7e79f5d2fb90
Autor:
Emmanuel Chimbunde, Lovemore N. Sigwadhi, Jacques L. Tamuzi, Elphas L. Okango, Olawande Daramola, Veranyuy D. Ngah, Peter S. Nyasulu
Publikováno v:
Frontiers in Artificial Intelligence, Vol 6 (2023)
BackgroundCOVID-19 has strained healthcare resources, necessitating efficient prognostication to triage patients effectively. This study quantified COVID-19 risk factors and predicted COVID-19 intensive care unit (ICU) mortality in South Africa based
Externí odkaz:
https://doaj.org/article/bcc7d265d813424dbb0be8465e2750a4
Autor:
Ayanda Trevor Mnguni, Denzil Schietekat, Nabilah Ebrahim, Nawhaal Sonday, Nicholas Boliter, Neshaad Schrueder, Shiraaz Gabriels, Lovemore N. Sigwadhi, Annalise E. Zemlin, Zivanai C. Chapanduka, Veranyuy Ngah, Anteneh Yalew, Thumeka Jalavu, Ibtisam Abdullah, Jacques L. Tamuzi, Yamanya Tembo, Mary-Ann Davies, Rene English, Peter S. Nyasulu
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background The coronavirus disease 2019 (COVID-19) pandemic continues to evolve. Globally, COVID-19 continues to strain even the most resilient healthcare systems, with Omicron being the latest variant. We made a thorough search for literatu
Externí odkaz:
https://doaj.org/article/952e2ef5fa784891843f351a05475103
Autor:
Ayanda Trevor Mnguni, Denzil Schietekat, Nabilah Ebrahim, Nawhaal Sonday, Nicholas Boliter, Neshaad Schrueder, Shiraaz Gabriels, Annibale Cois, Jacques L Tamuzi, Yamanya Tembo, Mary-Ann Davies, Rene English, Peter S Nyasulu
Publikováno v:
PLoS ONE, Vol 18, Iss 10, p e0277995 (2023)
BackgroundCOVID-19 experiences on noncommunicable diseases (NCDs) from district-level hospital settings during waves I and II are scarcely documented. The aim of this study is to investigate the NCDs associated with COVID-19 severity and mortality in
Externí odkaz:
https://doaj.org/article/839a43b48af14c7db532c26b6553b7c2
Autor:
Patrick DMC. Katoto, Jacques L. Tamuzi, Amanda S. Brand, Diana M. Marangu, Liliane N. Byamungu, Charles S. Wiysonge, Glenda Gray
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
The rapid emergence of COVID-19 variants of concern (VOCs) has hindered vaccine uptake. To inform policy, we investigated the effectiveness of the BNT162b2 vaccination among adolescents against symptomatic and severe COVID-19 diseases using mostly re
Externí odkaz:
https://doaj.org/article/c1cf477b6c134338a0f4add080e16e7e
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0276411 (2023)
BackgroundHuman Immunodeficiency Virus (HIV) significantly affects adolescents globally, with the sub-Saharan Africa (SSA) reporting a high burden of the disease. HIV testing, treatment, and retention to care are low among adolescents. We conducted a
Externí odkaz:
https://doaj.org/article/466523348bcf4a709c3a4660e080628c
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Understanding the occurrence of yellow fever epidemics is critical for targeted interventions and control efforts to reduce the burden of disease. We assessed data on the yellow fever incidence and mortality rates in Africa. Metho
Externí odkaz:
https://doaj.org/article/c78a58a0071648f5a90afe376a20e7ea
Autor:
Patrick D. M. C. Katoto, Amanda S. Brand, Liliane N. Byamungu, Jacques L. Tamuzi, Tamirirashe C. Mahwire, Marcel K. Kitenge, Charles S. Wiysonge, Glenda Gray
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
The COVID-19 pandemic has severely affected adolescents. Safe and effective vaccines are pivotal tools in controlling this pandemic. We reviewed the safety profile of the BNT162b2 COVID-19 vaccine in adolescents using mostly real-world data to assist
Externí odkaz:
https://doaj.org/article/56d32e80c0e74e4c981ac25f10a11688